PF-Atlas › Clinical Trials › NCT03260556

Pirfenidone for Progressive Fibrotic Sarcoidosis

Pirfenidone · Phase 4

Registry ID
NCT03260556
Phase
Phase 4
Status
Unknown
Drug / intervention
Pirfenidone
Sponsor
University of Cincinnati
Start
2017-09-27
Enrollment
60
Locations
1

About this trial

Study comparing pirfenidone versus placebo for patients with advanced fibrotic sarcoidosis

View NCT03260556 on ClinicalTrials.gov →

Explore related

All Pirfenidone trialsAll IPF trials

Related trials

Pirfenidone — NCT00001959pirfenidone — NCT00662038Pirfenidone — NCT02951429Pirfenidone — NCT00287729Pirfenidone — NCT01504334Pirfenidone — NCT02932566
Medical disclaimer. This page summarizes public trial data for NCT03260556 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.